Eugene Braunwald

91.1k total citations · 27 hit papers
448 papers, 59.7k citations indexed

About

Eugene Braunwald is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eugene Braunwald has authored 448 papers receiving a total of 59.7k indexed citations (citations by other indexed papers that have themselves been cited), including 368 papers in Cardiology and Cardiovascular Medicine, 151 papers in Surgery and 114 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eugene Braunwald's work include Acute Myocardial Infarction Research (188 papers), Cardiac Imaging and Diagnostics (111 papers) and Coronary Interventions and Diagnostics (77 papers). Eugene Braunwald is often cited by papers focused on Acute Myocardial Infarction Research (188 papers), Cardiac Imaging and Diagnostics (111 papers) and Coronary Interventions and Diagnostics (77 papers). Eugene Braunwald collaborates with scholars based in United States, Canada and United Kingdom. Eugene Braunwald's co-authors include Robert A. Kloner, Marc A. Pfeffer, Christopher P. Cannon, Carolyn H. McCabe, David A. Morrow, Sabina A. Murphy, C. Michael Gibson, Elliott M. Antman, Jean L. Rouleau and John D. Rutherford and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eugene Braunwald

437 papers receiving 56.7k citations

Hit Papers

Effect of Captopril on Mortality and Morbidity in Patient... 1979 2026 1994 2010 1992 2004 2015 1982 2005 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
    1992 4.4k citations Marc A. Pfeffer, Eugene Braunwald et al. profile →
  2. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
    2004 3.4k citations Christopher P. Cannon, Eugene Braunwald et al. profile →
  3. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
    2015 2.9k citations Michael A. Blazing, Robert P. Giugliano et al. profile →
  4. The stunned myocardium: prolonged, postischemic ventricular dysfunction.
    1982 2.1k citations Eugene Braunwald, Robert A. Kloner Circulation profile →
  5. C-Reactive Protein Levels and Outcomes after Statin Therapy
    2005 1.7k citations Christopher P. Cannon, David A. Morrow et al. profile →
  6. Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction
    1985 1.4k citations James E. Muller, Peter H. Stone et al. profile →
  7. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
    2011 1.3k citations Eugene Braunwald, Deepak L. Bhatt et al. profile →
  8. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
    2005 1.3k citations Marc S. Sabatine, C. Michael Gibson et al. profile →
  9. Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
    1996 1.3k citations Elliott M. Antman, Bruce Thompson et al. profile →
  10. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation
    2000 1.1k citations David A. Morrow, Elliott M. Antman et al. Circulation profile →
  11. Myocardial reperfusion: a double-edged sword?
    1985 1.1k citations Eugene Braunwald, Robert A. Kloner profile →
  12. Myocardial infarct size and ventricular function in rats.
    1979 1.1k citations Marc A. Pfeffer, Robert A. Kloner et al. profile →
  13. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
    2000 1.1k citations Lars Køber, Marc A. Pfeffer et al. profile →
  14. Unstable angina. A classification.
    1989 1.0k citations Eugene Braunwald Circulation profile →
  15. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
    2001 991 citations James A. de Lemos, David A. Morrow et al. profile →
  16. Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
    1988 824 citations Marc A. Pfeffer, Eugene Braunwald et al. profile →
  17. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
    2018 776 citations David A. Morrow, Eugene Braunwald et al. profile →
  18. Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
    1998 721 citations Marc A. Pfeffer, Eugene Braunwald et al. Circulation profile →
  19. A Tale of Coronary Artery Disease and Myocardial Infarction
    2012 674 citations Eugene Braunwald et al. profile →
  20. Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs
    2000 648 citations C. Michael Gibson, Christopher P. Cannon et al. Circulation profile →
  21. Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
    1985 636 citations Marc A. Pfeffer, Eugene Braunwald et al. profile →
  22. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy
    1998 599 citations David A. Morrow, Nader Rifai et al. Journal of the American College of Cardiology profile →
  23. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
    1993 569 citations Eugene Braunwald et al. profile →
  24. Reversible ischemic left ventricular dysfunction: Evidence for the “hibernating myocardium”
    1986 519 citations Eugene Braunwald et al. Journal of the American College of Cardiology profile →
  25. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
    2009 488 citations Eugene Braunwald, C. Michael Gibson et al. profile →
  26. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
    1989 427 citations Eugene Braunwald Circulation profile →
  27. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
    2016 249 citations Marc P. Bonaca, Deepak L. Bhatt et al. Journal of the American College of Cardiology profile →

Peers

Eugene Braunwald
Comparison fields: 5 of 189
  • Cardiology and Cardiovascular Medicine 43.0k
  • Surgery 20.7k
  • Radiology, Nuclear Medicine and Imaging 12.5k
  • Endocrinology, Diabetes and Metabolism 5.6k
  • Internal Medicine 4.5k
Replace Eugene Braunwald with:
Eugene Braunwald United States
Harvey D. White New Zealand
Christopher B. Granger United States
Christopher P. Cannon United States
Bernard J. Gersh United States
Elliott M. Antman United States
James T. Willerson United States
Carolyn H. McCabe United States
Keith A.A. Fox United Kingdom
Frans Van de Werf Belgium
Eugene Braunwald United States View profile →
Citations per field, relative to Eugene Braunwald
Eugene Braunwald · 1×
Citations per year, relative to Eugene Braunwald
Eugene Braunwald · 1×

Countries citing papers authored by Eugene Braunwald

Since Specialization
Citations

This map shows the geographic impact of Eugene Braunwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Braunwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Braunwald more than expected).

Fields of papers citing papers by Eugene Braunwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Braunwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Braunwald. The network helps show where Eugene Braunwald may publish in the future.

Co-authorship network of co-authors of Eugene Braunwald

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Braunwald. A scholar is included among the top collaborators of Eugene Braunwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Braunwald. Eugene Braunwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Mortality After High-Risk Myocardial Infarction Over the Last 20 Years: Insights from the VALIANT and PARADISE-MI Trials
2024 ·European Journal of Heart Failure ·Alberto Foà, Maria Pabón, Eugene Braunwald, Karola Jering, Muthiah Vaduganathan, Brian Claggett, Lars Køber, Eldrin F. Lewis, Christopher B. Granger, Peter van der Meer, Jean L. Rouleau, Aldo P. Maggioni, John J.V. McMurray, Scott Solomon, Marc A. Pfeffer
3
2
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation
2024 ·JAMA Cardiology ·André Zimerman, Eugene Braunwald, Jan Steffel, Nicolas M. Van Mieghem, (unknown), Sabina A. Murphy, (unknown), Martin Unverdorben, Christian T. Ruff, Elliott M. Antman, Robert P. Giugliano
11
3
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
2024 ·Nature Medicine ·Nicholas Marston, James P. Pirruccello, Giorgio Melloni, Frederick Kamanu, Marc P. Bonaca, Robert P. Giugliano, Benjamin M. Scirica, Stephen D. Wiviott, Deepak L. Bhatt, Philippe Gabríel Steg, Itamar Raz, Eugene Braunwald, Peter Libby, Patrick T. Ellinor, Alexander G. Bick, Marc S. Sabatine, Christian T. Ruff
17
4
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
2023 ·European Journal of Heart Failure ·Siddharth M. Patel, David A. Morrow, Andrea Bellavia, David D. Berg, Deepak L. Bhatt, Petr Jarolı́m, Lawrence A. Leiter, Darren K. McGuire, Itamar Raz, Philippe Gabríel Steg, John Wilding, Marc S. Sabatine, Stephen D. Wiviott, Eugene Braunwald, Benjamin M. Scirica, Erin A. Bohula
4
5
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome
2018 ·Journal of the American College of Cardiology ·C. Michael Gibson, Bennett Levitan, William J. Gibson, Megan K. Yee, Sabina A. Murphy, Žhong Yuan, Anjan Chakrabarti, Michael Lee, Eugene Braunwald
12
6
RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL
2014 ·Rational Pharmacotherapy in Cardiology ·(unknown), Eugene Braunwald, Sabina A. Murphy, Alexei N. Plotnikov, (unknown), Róbert Gábor Kiss, Alexander Parkhomenko, Michał Tendera, Petr Widimský, C. Michael Gibson
2
7
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
2014 ·American Heart Journal ·Michael A. Blazing, Robert P. Giugliano, Christopher P. Cannon, (unknown), Andrew M. Tershakovec, Jennifer A. White, Martin Craig, (unknown), Eugene Braunwald, Robert M. Califf
80
8
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial
2014 ·American Heart Journal ·Marc P. Bonaca, Deepak L. Bhatt, Eugene Braunwald, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Peter Held, Eva C. Jensen, Marc S. Sabatine
73
9
Vorapaxar in Patients With Peripheral Artery Disease
2013 ·Circulation ·Marc P. Bonaca, Benjamin M. Scirica, Mark A. Creager, Jeffrey W. Olin, H Bounameaux, (unknown), (unknown), Sabina A. Murphy, Eugene Braunwald, David A. Morrow
210
10
Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22
2012 ·Circulation ·Ryan B. O’Malley, David A. Morrow, Marc P. Bonaca, Petr Jarolı́m, Benjamin M. Scirica, Sabina A. Murphy, Michael Conrad, Christopher P. Cannon, Eugene Braunwald, Marc S. Sabatine
2
11
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
2011 ·Circulation ·Marc S. Sabatine, David A. Morrow, James A. de Lemos, Torbjørn Omland, Sarah Sloan, Petr Jarolı́m, Scott D. Solomon, Marc A. Pfeffer, Eugene Braunwald
108
12
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial
2010 ·European Heart Journal ·Benjamin M. Scirica, David A. Morrow, Christoph Bode, Witold Rużyłło, Mikhail Ruda, A. J. M. Oude Ophuis, José López‐Sendón, Karl Swedberg, (unknown), Nader Rifai, Valentina Lukashevich, Mojdeh Maboudian, Christopher P. Cannon, Carolyn H. McCabe, Eugene Braunwald
38
13
Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial
2005 ·Circulation ·Marc S. Sabatine, David A. Morrow, Gilles Montalescot, Mikael Dellborg, José L. Leiva-Pons, Mátyás Keltai, Sabina A. Murphy, Carolyn H. McCabe, C. Michael Gibson, Christopher P. Cannon, Elliott M. Antman, Eugene Braunwald
50
14
Reperfusion therapy for acute myocardial infarction: historical context and future promise
2002 ·European Heart Journal Supplements ·Eugene Braunwald
14
15
Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction
2001 ·Matthew T. Roe, Robert P. Giugliano, Robert A. Harrington, C. Michael Gibson, John Strony, Michael M. Kitt, Robert M. Califf, Eugene Braunwald
5
16
Rates of Serious Bleeding Events Requiring Transfusion in AMI Patients Treated with TNK-tPA
1999 ·Journal of the American College of Cardiology ·(unknown), (unknown), (unknown), (unknown), Thierry Danays, (unknown), Eugene Braunwald, Frans Van de Werf
3
17
Abciximab + tPA Improves Coronary Flow in a Wide Range of Subgroups: Results from TIMI 14
1998 ·Circulation ·Robert P. Giugliano, Elliott M. Antman, Carolyn H. McCabe, (unknown), A.A.J. Adgey, (unknown), (unknown), (unknown), Eugene Braunwald
4
18
Circadian Variation in the Onset of Unstable Angina and Non-Q-Wave Acute Myocardial Infarction (The TIMI III Registry and TIMI IIIB)
1997 ·The American Journal of Cardiology ·Christopher P. Cannon, Carolyn H. McCabe, Peter H. Stone, Mark Schactman, Bruce Thompson, Pierre Théroux, Robert S. Gibson, Ted Feldman, Neal S. Kleiman, Geoffrey H. Tofler, James E. Muller, Bernard Chaitman, Eugene Braunwald
99
19
Myocardial ischemia, infarction, and failure: an odyssey.
1994 ·PubMed ·Eugene Braunwald
3
20
The stunned myocardium: prolonged, postischemic ventricular dysfunction. breakdown →
1982 ·Circulation ·Eugene Braunwald, Robert A. Kloner
2063

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Harvey D. White Breakdown of academic impact, for papers by Christopher B. Granger Breakdown of academic impact, for papers by Christopher P. Cannon Breakdown of academic impact, for papers by Bernard J. Gersh Breakdown of academic impact, for papers by Elliott M. Antman Breakdown of academic impact, for papers by James T. Willerson Breakdown of academic impact, for papers by Carolyn H. McCabe Breakdown of academic impact, for papers by Keith A.A. Fox Breakdown of academic impact, for papers by Frans Van de Werf
Rankless by CCL
2026